v3.25.2
Interim Balance Sheet - USD ($)
Jun. 30, 2025
Mar. 31, 2025
Dec. 31, 2024
Nov. 30, 2024
Sep. 30, 2024
Dec. 31, 2023
Sep. 30, 2023
Current Assets:              
Cash            
Non-current assets              
TOTAL ASSETS            
Current Liabilities:              
Accounts payable       5,984      
Total Current Liabilities       5,984      
TOTAL LIABILITIES       5,984      
Shareholders’ Deficit:              
Ordinary shares, $0.0001 par value; 500,000,000 shares authorized; 2,063,000 and 2,063,000 shares issued and outstanding (excluding 832,415 and 6,900,000 shares, subject to possible redemption as of June 30, 2025 and December 31, 2024, respectively)       0      
Additional paid-in capital       (0)      
Accumulated Deficit       (5,984)      
Total Shareholders’ Deficit       (5,984)      
TOTAL LIABILITIES AND SHAREHOLDERS’ DEFICIT            
Related Party [Member]              
Current Liabilities:              
Due to related party            
Maius Pharmaceutical Co. Ltd [Member]              
Current Assets:              
Cash   $ 1,809,035     $ 74,514   $ 179,237
Short-term investment       62,076   148,310
Amounts due from related parties   201,207     154,235   146,245
Prepaid expenses   239,685     155,282   101,649
Total Current Assets   2,249,927     446,107   575,441
Non-current assets              
Right-of-use assets, net   56,132     75,687   27,023
Property, plant and equipment   4,838     746   2,829
Intangible assets, net   773     859   969
Other noncurrent assets   844     865   844
Deferred offering costs   549,045     335,509   225,032
Total non-current assets   611,632     413,666   256,697
TOTAL ASSETS   2,861,559     859,773   832,138
Current Liabilities:              
Accounts payable   40,602     41,592   40,593
Salary and welfare payable   25,974     26,599   26,779
Other payable   66,236     1  
Lease liabilities, current   39,736     40,106   22,087
Convertible bond   300,000        
Total Current Liabilities   4,010,149     3,356,493   2,701,505
Lease liabilities, non-current   3,677     26,277  
TOTAL LIABILITIES   4,013,826     3,382,770   2,701,505
Commitments and contingencies        
Shareholders’ Deficit:              
Ordinary shares, $0.0001 par value; 500,000,000 shares authorized; 2,063,000 and 2,063,000 shares issued and outstanding (excluding 832,415 and 6,900,000 shares, subject to possible redemption as of June 30, 2025 and December 31, 2024, respectively)   14,619     13,727   13,727
Additional paid-in capital   13,160,402     11,074,192   11,074,192
Subscription receivables   (2,939,179)     (2,939,179)   (2,969,955)
Accumulated other comprehensive loss   (156,545)     (220,253)   (165,023)
Accumulated Deficit   (11,231,564)     (10,451,484)   (9,822,308)
Total Shareholders’ Deficit   (1,152,267)     (2,522,997)   (1,869,367)
TOTAL LIABILITIES AND SHAREHOLDERS’ DEFICIT   2,861,559     859,773   832,138
Maius Pharmaceutical Co. Ltd [Member] | Related Party [Member]              
Current Liabilities:              
Due to related party   3,537,601     $ 3,248,195   $ 2,612,046
DT Cloud Acquisition Corporation [Member]              
Current Assets:              
Cash   $ 152,021     $ 69,818  
Cash in escrow         425,000  
Prepaid expenses 45,242   16,830     8,446  
Total Current Assets 45,242   168,851     503,264  
Non-current assets              
Deferred offering costs         85,000  
Cash and Investments held in trust account 9,058,036   72,345,071      
TOTAL ASSETS 9,103,278   72,513,922     588,264  
Current Liabilities:              
Other payable 300,000          
Promissory note 545,975          
Accrued liabilities 76,584   168,060     24,247  
Total Current Liabilities 1,290,686   297,819     731,861  
Deferred Underwriting Compensation 1,725,000   1,725,000      
TOTAL LIABILITIES 3,015,686   2,022,819     731,861  
Commitments and contingencies          
Ordinary shares subject to possible redemption, 832,415 and 6,900,000 shares issued and outstanding at redemption value of $10.88 and $10.48 as of June 30, 2025 and December 31, 2024, respectively 9,058,036   72,345,071      
Shareholders’ Deficit:              
Ordinary shares, $0.0001 par value; 500,000,000 shares authorized; 2,063,000 and 2,063,000 shares issued and outstanding (excluding 832,415 and 6,900,000 shares, subject to possible redemption as of June 30, 2025 and December 31, 2024, respectively) 206   206     173  
Additional paid-in capital         24,827  
Accumulated Deficit (2,970,650)   (1,854,174)     (168,597)  
Total Shareholders’ Deficit (2,970,444) $ (2,500,178) (1,853,968)     (143,597)  
TOTAL LIABILITIES AND SHAREHOLDERS’ DEFICIT 9,103,278   72,513,922     588,264  
DT Cloud Acquisition Corporation [Member] | Related Party [Member]              
Current Liabilities:              
Due to related party $ 368,127   129,759     490,000  
Promissory note – related party         $ 217,614